Work

Abstract 3082: Activation mevalonate pathway via HMGCS2 introduced resistance to molecular targeted therapy for cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3082

Author: Yasuhiro Kato

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629492

Cites:

Cited by:

Related to: 10